• LAST PRICE
    0.8700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.8800/ 1
  • Ask / Lots
    0.9100/ 133
  • Open / Previous Close
    0.0000 / 0.8700
  • Day Range
    ---
  • 52 Week Range
    Low 0.3800
    High 1.2300
  • Volume
    587
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.8599
TimeVolumeSNGX
09:32 ET13100.8598
09:41 ET20000.86
09:48 ET1840.841
09:54 ET1000.85
09:56 ET3550.85
10:08 ET15100.8598
10:26 ET100000.8416
10:30 ET3000.841601
10:33 ET14000.8598
10:35 ET1170.859699
10:39 ET1000.8598
10:44 ET1000.8549
10:48 ET1000.8501
11:04 ET35000.8584
11:08 ET49980.86
11:13 ET6000.86
11:24 ET8030.8565
11:26 ET77000.8555
11:29 ET194000.8573
11:31 ET1000.8549
11:40 ET3000.8549
11:42 ET40290.85
11:44 ET1000.8501
11:45 ET5000.8501
11:47 ET11000.8501
11:49 ET2700.85
11:51 ET23400.85
11:54 ET1000.8501
12:07 ET1000.855001
12:20 ET17500.855051
12:27 ET1000.86
12:54 ET10000.855051
01:17 ET1250.8599
01:19 ET5000.859899
01:32 ET6000.8502
01:33 ET1000.86
01:50 ET9330.8506
02:11 ET5000.8504
02:13 ET1000.8504
02:22 ET45220.8853
02:27 ET1000.8505
02:31 ET10000.8599
02:54 ET1450.8506
02:56 ET3000.8506
03:07 ET4560.8506
03:16 ET1000.86
03:21 ET5530.8554
03:34 ET20520.8554
03:39 ET48000.8599
03:41 ET26520.8703
03:43 ET1000.87
03:45 ET5500.8502
03:54 ET1000.8704
03:59 ET15000.87
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSNGX
Soligenix Inc
37.0M
-2.5x
---
United StatesAPTX
Aptinyx Inc
46.7M
-0.5x
---
United StatesAIMD
Ainos Inc
31.2M
-5.2x
---
United StatesTRVN
Trevena Inc
39.7M
-0.7x
---
United StatesNNVC
NanoViricides Inc
35.6M
-3.6x
---
United StatesOTLC
Oncotelic Therapeutics Inc
34.1M
-2.9x
---
As of 2022-08-12

Company Information

Soligenix, Inc. is a late-stage biopharmaceutical company. The Company is focused on developing products to treat rare diseases. The Company operates through two segments: Specialized BioTherapeutics and Public Health Solutions. Specialized BioTherapeutics segments includes developing of HyBryte (SGX301 or synthetic hypericin) a photodynamic therapy for the treatment of cutaneous T-cell lymphoma (CTCL). Public Health Solutions segment includes RiVax to protect against exposure to ricin toxin vaccine candidate and SGX943 therapeutic candidate for antibiotic resistant and infectious disease. The Company's Development programs include innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of inflammatory diseases, oral mucositis in head and neck cancer, and oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) disorders including pediatric Crohn's disease (SGX203).

Contact Information

Headquarters
SUITE C-10, 29 EMMONS DRIVEPRINCETON, NJ, United States 08540
Phone
609-538-8200
Fax
609-452-6467

Executives

Chairman of the Board, Chief Executive Officer and President
Christopher Schaber
Chief Financial Officer, Senior Vice President, Corporate Secretary
Jonathan Guarino
Senior Vice President, Chief Scientific Officer
Oreola Donini
Senior Vice President and Chief Medical Officer
Richard Straube
Independent Director
Gregg Lapointe

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$37.0M
Revenue (TTM)
$864.7K
Shares Outstanding
43.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.34
EPS
$-0.35
Book Value
$0.25
P/E Ratio
-2.5x
Price/Sales (TTM)
42.8
Price/Cash Flow (TTM)
---
Operating Margin
-1,698.60%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.